(S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid

We are (S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid CAS:85977-52-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid
CAS.NO:  85977-52-2
Synonyms:
(1S)-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid

Molecular Formula: C11H12O2
Molecular Weight:  176.21200

Physical and Chemical Properties:
Density: 1.186 g / cm3
Boiling point: 54-56 ° C
Melting point: 54-56 ° C
Flash point: 156.4ºC
Refractive index: 1.576

Specification:
Appearance:Crystalline white or yellow powder
Purity:≥99%
Inorganic salt:≤0.1%
Loss on drying:≤0.1%
Heavy metals:≤10 ppm
Water:≤0.1%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Palonosetron hydrochloride CAS:135729-61-2

Related News: The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.Cloruro de 3- (trifluorometoxi) benzoilo CAS:86270-03-3 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.Clorhidrato de N-metil-1-naftalenometilamina CAS:65473-13-4 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs. 3-fluoropiridina CAS:372-47-4 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.